Mark Hellberg

Mark Hellberg is a seasoned professional in the pharmaceutical and biotechnology sectors, currently serving as a Sr Consultant at Atheln, Inc. since March 2023. Prior to this role, Mark held significant positions at Novartis Institutes for BioMedical Research as Executive Director from August 2013 to February 2022, and at Alcon as Senior Director from August 1990 to August 2013. Mark began a career in the industry as a Scientist at AH Robins from 1985 to 1990. Mark earned a degree from Virginia Commonwealth University, contributing to a robust background that emphasizes risk identification and mitigation in product development and commercialization strategies.